Searched for: in-biosketch:yes
person:kolode01
Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect
Navon, R; Kolodny, E H; Mitsumoto, H; Thomas, G H; Proia, R L
The adult form of Tay-Sachs disease, adult GM2 gangliosidosis, is an autosomal recessive neurological disorder caused by a partial deficiency of beta-hexosaminidase A. We had previously identified, in Ashkenazi-Jewish adult GM2 gangliosidosis patients, a Gly269----Ser mutation in the beta-hexosaminidase alpha-subunit. All of the Ashkenazi patients were found to be compound heterozygotes with an allele containing the Gly269----Ser mutation together with one of the Ashkenazi infantile Tay-Sachs alleles. We have now found the same Gly269----Ser mutation in six adult GM2 gangliosidosis patients from four different non-Jewish families. Genomic DNA from three of the patients, two of whom were brothers, exhibited a hybridization pattern consistent with homozygosity for the Gly269----Ser mutation. The remaining non-Jewish patients were compound heterozygotes of the Gly269----Ser mutation together with an unidentified alpha-subunit mutation. The results demonstrate that individuals homozygous for the Gly269----Ser change can be clinically affected. The same Gly269----Ser mutation in both the Ashkenazi and non-Jewish patients may be the result of a common ancestor, given that the ancestry of these non-Jewish patients, like the Ashkenazim, can be traced to eastern Europe
PMCID:1683663
PMID: 2278539
ISSN: 0002-9297
CID: 75035
Genotype assignment in Gaucher disease by selective amplification of the active glucocerebrosidase gene
Firon, N; Eyal, N; Kolodny, E H; Horowitz, M
Genomic DNA prepared from human cells in culture was amplified by the polymerase chain-reaction technique using two primers specific for the active human glucocerebrosidase gene. The 1,036-bp amplified fragment derived from the active gene was tested for the existence of three mutations--designated '370,' 'NciI,' and 'HhaI'--by allele-specific oligonucleotide hybridization. The results obtained from the cell lines examined permitted a clear distinction between homozygous affected, heterozygous, and normal genotypes. However, 28% of the possible affected loci were normal with respect to the three mutations, indicating the presence of additional mutations that remain to be elucidated. While the NciI mutation could be found in both Ashkenazi Jewish and non-Jewish type 1 patients, the only homozygotes with this mutation had the neurological (type 2 or type 3) form of the disease. The 370 mutation, on the other hand, was only present in type 1 patients and was not identified among any of the patients with neurologic forms of the disease
PMCID:1683624
PMID: 2309702
ISSN: 0002-9297
CID: 75036
Corneal surface irregularities and episodic pain in a patient with mucolipidosis IV [Case Report]
Newman, N J; Starck, T; Kenyon, K R; Lessell, S; Fish, I; Kolodny, E H
Mucolipidosis IV is a lysosomal storage disease characterized by prominent involvement of the corneal epithelium. A 5-year-old boy with mucolipidosis IV experienced recurrent episodes of severe ocular pain, tearing, and ipsilateral facial flushing. This was suggestive of reflex sympathetic dystrophy, a syndrome of pain and sympathetic hyperactivity. The examination revealed marked corneal surface irregularities, corresponding to massive accumulations of intracytoplasmic storage material in the epithelium. Episodic pain in patients with mucolipidosis IV is an important symptom, presumably reflecting the distinctive corneal ultrastructural abnormality in this disease
PMID: 2302112
ISSN: 0003-9950
CID: 75037
GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients
Tanaka, A; Ohno, K; Sandhoff, K; Maire, I; Kolodny, E H; Brown, A; Suzuki, K
A single nucleotide transition within exon 5 of the beta-hexosaminidase alpha chain gene was identified in a Puerto Rican patient with GM2-gangliosidosis B1 variant as the mutation responsible for the unusual enzymological characteristics of this variant (G533----A; Arg178----His) (the DN-allele). A total of seven patients with enzymological characteristics of B1 variant have since been studied. They were Puerto Rican (DN), Italian, French, Spanish, two patients of mixed ethnic origin (English/Italian/Hungarian and English/French/Azores), and a Czechoslovakian. In confirmation of our earlier finding based on screening with allele-specific probes, all patients except the one from Czechoslovakia carried the same DN-allele. A new point mutation found in this patient changed the same codon affected in the DN-allele (C532----T; Arg178----Cys). An asymptomatic Japanese individual included as a control also carried one allele with the DN-mutation. Site-directed mutagenesis and expression studies in COS I cells demonstrated that either of the two point mutations abolishes the catalytic activity of the alpha subunit. The Spanish patient was homozygous for the DN-allele, but others were all compound heterozygotes. The Puerto Rican patient was a compound heterozygote with the DN-mutation in one allele and with the four-base insertion in exon 11, one of the two mutations found in the classical Ashkenazi Jewish Tay-Sachs disease, in the other allele. Abnormalities of the other allele were not identified in all other compound heterozygous patients. In these patients, the level of mRNA derived from the other allele was variable, ranging from being undetectable to being much lower than normal. This series of studies uncovered a new B1 variant mutation, confirmed our preliminary finding that the DN-allele has a surprisingly wide geographic and ethnic distribution, and pointed out the highly complex nature of the molecular genetics of this rare disorder. They also support our working hypothesis that mutations responsible for the unique enzymological characteristics of the B1 variant should be located in or near exon 5 of the gene and that this region of the enzyme protein is critical for its catalytic function
PMCID:1684994
PMID: 2137287
ISSN: 0002-9297
CID: 75038
Animal models for lysosomal storage diseases: their past and future contribution
Alroy, J; Warren, C D; Raghavan, S S; Kolodny, E H
PMID: 2673978
ISSN: 0046-8177
CID: 75039
NEURONAL CEROID LIPOFUSCINOSIS - CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN A REVIEW OF 262 CASES [Meeting Abstract]
PATXOT, OF; WISNIEWSKI, KE; KITAGUCHI, T; DYKEN, P; PHILIPPART, M; KOLODNY, EH
ISI:A1989AP76800162
ISSN: 0364-5134
CID: 74959
Agenesis of the corpus callosum: a marker for inherited metabolic disease?
Kolodny, E H
PMID: 2725881
ISSN: 0028-3878
CID: 75040
Early cerebellar degeneration in twins with infantile neuroaxonal dystrophy [Case Report]
Barlow, J K; Sims, K B; Kolodny, E H
Dizygotic twin girls with typical infantile neuroaxonal dystrophy (INAD) were studied at age 19 months with computed tomography and magnetic resonance imaging (MRI). Both methods showed distinct atrophy confined to the cerebellum and MRI revealed diffuse signal abnormality of the cerebellar parenchyma. This neuro-imaging evidence for selective early involvement of the cerebellum is consistent with both the typical presenting symptoms and the gross pathological findings in the disorder. Neuroimaging may aid in differentiation of INAD from other neurodegenerative disorders with onset in late infancy, providing impetus for diagnostic biopsy and early genetic counseling
PMID: 2540694
ISSN: 0364-5134
CID: 75041
Familial spastic paraplegia: clinical observations and genetic studies [Case Report]
Kolodny, E H; Boustany, R M; Rouleau, G A; Growden, J H; Martin, J B
PMID: 2740411
ISSN: 0361-7742
CID: 75042
Neurological progress. The neuronal ceroid lipofuscinoses: a review
Boustany, R M; Kolodny, E H
Neuronal ceroid lipofuscinosis is a common cause of neurodegenerative disease in children. The disease is characterized by visual failure, seizures and dementia. The presence of cortical atrophy by computerized axial tomography and distinctive ultrastructural findings by skin biopsy, together with a suggestive clinical course and neurophysiologic abnormalities, lead to a diagnosis. Presently four subtypes and rare atypical forms are recognized: the infantile, late infantile, juvenile and adult or Kufs variants and atypical early juvenile and protracted juvenile types. The inheritance pattern is autosomal recessive in all subtypes with some of the adult cases representing autosomal dominant inheritance. The biochemical characterization of this disorder is just beginning. There is some evidence to implicate overglycosylation of proteins as playing a role in pathogenesis. Further biochemical description coupled with linkage analysis techniques using DNA probes are needed to develop a better understanding of this group of disorders
PMID: 2657976
ISSN: 0035-3787
CID: 75043